Health Alert: First drug specifically for postpartum depression is approved

The Food and Drug Administration approved a new drug for postpartum depression — a debilitating condition that begins during pregnancy or within a month of childbirth and affects hundreds of thousands of women a year in the United States. The drug is administered intravenously over 60 hours and, in clinical trials, began taking effect within hours, compared to several weeks for existing treatments.

Democracy Dies in Darkness     Health Alert Mar 19, 5:51 PM     First drug specifically for postpartum depression is approved The Food and Drug Administration approved a new drug for postpartum depression — a debilitating condition that begins during pregnancy or within a month of childbirth and affects hundreds of thousands of women a year in the United States. The drug is administered intravenously over 60 hours and, in clinical trials, began taking effect within hours, compared to several weeks for existing treatments. Read more » Advertisement You received this email because you signed up for news alerts from The Washington Post. Manage my newsletters and alerts | Unsubscribe Privacy Policy | Help ©2019 The Washington Post, 1301 K St NW, Washington DC 20071